Nanomix Appoints Industry Veteran Tadd S. Lazarus, M.D., to the Board of Directors
SAN LEANDRO, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in...
Month: August 2022
MiNK Therapeutics to Participate at Upcoming Investor Conferences
NEW YORK, Aug. 31, 2022 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering the discovery, development, and...
AMN Healthcare’s Steve Wehn Named Board Chair of International Esperanza Project
DALLAS, Aug. 31, 2022 (GLOBE NEWSWIRE) -- International Esperanza Project (IEP), a Dallas-based nonprofit whose mission is to inspire hope...
BrainsWay to Present at the H.C. Wainwright Annual Global Investment Conference
BURLINGTON, Mass. and JERUSALEM, Aug. 31, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...
BBS-Bioactive Bone Substitutes Plc: Managers’ Transactions – Pekka Jalovaara
BBS-Bioactive Bone Substitutes Plc, Company Announcement, 31 August 2022 16.00 (CEST) BBS Bioactive Bone Substitutes Oyj - Managers' Transactions ____________________________________________...
BBS-Bioactive Bone Substitutes Plc: Managers’ Transactions – Ahti Paananen
BBS-Bioactive Bone Substitutes Plc, Company Announcement, 31 August 2022 16.00 (CEST) BBS Bioactive Bone Substitutes Oyj - Managers' Transactions ____________________________________________...
Lumos Pharma to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
AUSTIN, Texas, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing a novel oral therapeutic candidate,...
Alimera Announces Multiple Abstracts Highlighting ILUVIEN® Real World Data at EURETINA Annual Congress
Positive findings from the RIVER study and data on retreatment with ILUVIEN availableATLANTA, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Alimera...
AVEO Oncology Announces Participation at Investor Conferences in September
BOSTON, Aug. 31, 2022 (GLOBE NEWSWIRE) -- AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company committed to delivering...
U.S. Food and Drug Administration (FDA) Grants Fast Track Designation for Longeveron’s Lomecel-B™ Product for Treatment of Hypoplastic Left Heart Syndrome (HLHS) in Infants
New designation may expedite FDA review and potential approval to address this life-threatening heart condition affecting approximately 1,000 babies per...
WIMI Hologram Academy: The Synergy of Interaction between Holographic Technology and Geography
WIMI Hologram Academy: The Synergy of Interaction between Holographic Technology and GeographyHONG KONG, Aug. 31, 2022 (GLOBE NEWSWIRE) -- WIMI...
Allied Corp. Successfully Ships 3425kgs – The Largest International Cannabis Shipment in History
Allied Corp. is the first company to successfully produce and ship commercial cannabis flower from Colombia to an international market...
Vaxart Names Biotech Veteran Ray Stapleton Chief Technology Officer
Dr. Stapleton has more than 20 years of industry experience leading technical, quality and manufacturing operations at commercial and clinical...
Blue Water Vaccines to Present at H.C. Wainwright’s 24th Annual Global Investment Conference in New York, NY
CINCINNATI, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”) a...
X4 Pharmaceuticals to Host Investor Webinar Highlighting New Mavorixafor Phase 1b Data in Chronic Neutropenia
Webcast to take place on September 27 at 8:00 a.m. ET, followed by live Q&ABOSTON, Aug. 31, 2022 (GLOBE NEWSWIRE)...
Ascendis Pharma Submits TransCon™ PTH New Drug Application to the U.S. FDA for Adult Patients with Hypoparathyroidism
• TransCon PTH could, if approved, become the first hormone replacement therapy to address the underlying cause of hypoparathyroidism, an...
Akoya to Participate at Four Upcoming Investor Conferences
MARLBOROUGH, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced...
Araris Biotech AG to Present at 13th Annual World ADC San Diego 2022
AU ZH, Switzerland, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Araris Biotech AG, a company pioneering a proprietary antibody-drug conjugate (ADC)-linker...
Vyant Bio to Present at the H.C. Wainwright 24th Annual Global Investment Conference
CHERRY HILL, N.J., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an...
BBS-Bioactive Bone Substitutes Plc: Change in BBS-Bioactive Bonesubstitutes Plc’s management
BBS-Bioactive Bone Substitutes Plc, Company Announcement, 31 August 2022 15.00 (CEST) BBS-Bioactive Bonesubstitutes Plc's CFO and member of the management...